In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 32.6 | 27.1 | 31.1 | 39.4 | 41.9 | 33.3 | 35.3 | 30.5 | 33.5 | 33.3 | 28.1 | 30.1 | |
| Other Income | 0.2 | 0.6 | 0.9 | 1.2 | 0.6 | 1.4 | 0.6 | 1.0 | 1.9 | 0.7 | 0.9 | 0.9 | |
| Total Income | 32.8 | 27.7 | 32.1 | 40.6 | 42.5 | 34.7 | 36.0 | 31.5 | 35.4 | 34.0 | 29.0 | 31.0 | |
| Expenses | |||||||||||||
| + Employee Benefit Expense | 13.5 | 15.2 | 16.6 | 15.7 | 16.7 | 14.7 | 15.6 | 17.6 | 14.6 | 18.5 | 14.5 | 17.9 | |
| + Finance Costs | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | |
| + Depreciation & Amortisation | 0.4 | 0.8 | 0.8 | 1.2 | 1.2 | 1.2 | 1.3 | 1.6 | 1.6 | 1.6 | 1.8 | 0.9 | |
| + Other Expenses | 12.2 | 6.2 | 10.8 | 16.0 | 18.3 | 15.1 | 16.0 | 10.7 | 15.3 | 11.4 | 10.5 | 11.6 | |
| Total Expenses | 26.2 | 22.3 | 28.2 | 33.0 | 36.3 | 31.1 | 33.0 | 30.1 | 31.6 | 31.6 | 26.9 | 30.5 | |
| EBITDA | 6.9 | 5.7 | 3.8 | 7.6 | 6.8 | 3.5 | 3.7 | 2.2 | 3.6 | 3.4 | 3.2 | 0.6 | |
| EBIT | 6.5 | 5.0 | 3.0 | 6.5 | 5.6 | 2.2 | 2.4 | 0.6 | 2.0 | 1.8 | 1.3 | -0.3 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 6.6 | 5.4 | 3.9 | 7.6 | 6.2 | 3.6 | 3.0 | 1.4 | 3.9 | 2.4 | 2.1 | 0.5 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -31.6 | 0.0 | |
| Pretax Income | 6.6 | 5.4 | 3.9 | 7.6 | 6.2 | 3.6 | 3.0 | 1.4 | 3.9 | 2.4 | -29.5 | 0.5 | |
| + Current Tax | 1.5 | 1.1 | 0.7 | 1.9 | 1.3 | 0.5 | 0.3 | 0.2 | 0.5 | 0.2 | -0.2 | 0.2 | |
| + Deferred Tax | -0.1 | 0.0 | 0.1 | 0.1 | -0.1 | 0.0 | -0.1 | -0.0 | 0.2 | -0.1 | -6.9 | -0.5 | |
| Tax Expense | 1.4 | 1.1 | 0.9 | 2.1 | 1.2 | 0.5 | 0.3 | 0.1 | 0.7 | 0.1 | -7.1 | -0.4 | |
| Net Income | 5.1 | 4.3 | 3.0 | 5.5 | 5.0 | 3.1 | 2.7 | 1.3 | 3.2 | 2.3 | -22.4 | 0.9 | |
| + Net Income — Continuing Ops | 5.1 | 4.3 | 3.0 | 5.5 | 5.0 | 3.1 | 2.7 | 1.3 | 3.2 | 2.3 | -22.4 | 0.9 | |
| + Other Comprehensive Income | 0.2 | 0.4 | 0.6 | 0.6 | 0.6 | -0.6 | -0.0 | 0.3 | 0.6 | 0.4 | -0.6 | -0.1 | |
| Total Comprehensive Income | 5.4 | 4.7 | 3.6 | 6.1 | 5.6 | 2.5 | 2.7 | 1.5 | 3.7 | 2.7 | -23.0 | 0.8 | |
| Per Share | |||||||||||||
| Basic EPS | 2.19 | 1.83 | 1.28 | 2.34 | 2.13 | 1.31 | 1.21 | 0.54 | 1.34 | 1.01 | -9.58 | 0.37 | |
| Diluted EPS | 2.19 | 1.82 | 1.27 | 2.33 | 2.12 | 1.31 | 1.14 | 0.52 | 1.28 | 0.97 | -9.22 | 0.36 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -0.0 | 0.3 | 0.6 | 0.4 | -0.6 | -0.1 | |
| + Items NOT to be Reclassified to P&L | -0.1 | -0.1 | 0.4 | -0.0 | 0.2 | -0.1 | -0.1 | — | — | — | -0.8 | — | |
| + Items to be Reclassified to P&L | 0.3 | 0.5 | 0.3 | 0.6 | 0.4 | -0.5 | 0.0 | 0.3 | 0.6 | 0.4 | 0.2 | -0.1 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 2.19 | 1.83 | 1.28 | 2.34 | 2.13 | 1.31 | 1.21 | 0.54 | 1.34 | 1.01 | -9.58 | 0.37 | |
| Diluted EPS — Continuing Operations | 2.19 | 1.82 | 1.27 | 2.33 | 2.12 | 1.31 | 1.14 | 0.52 | 1.28 | 0.97 | -9.22 | 0.36 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 32.6 | 27.1 | 31.1 | 39.4 | 41.9 | 33.3 | 35.3 | 30.5 | 33.5 | 33.3 | 28.1 | 30.1 | |
| Gross Margin % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 6.6 | 5.4 | 3.9 | 7.6 | 6.2 | 3.6 | 3.0 | 1.4 | 3.9 | 2.4 | 2.1 | 0.5 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -31.6 | 0.0 | |
| Net Income Adj (tax-effected) | 5.1 | 4.3 | 3.0 | 5.5 | 5.0 | 3.1 | 2.7 | 1.3 | 3.2 | 2.3 | 1.6 | 0.9 | |
| EPS Adj | 2.19 | 1.83 | 1.28 | 2.34 | 2.13 | 1.31 | 1.21 | 0.54 | 1.34 | 1.01 | 0.69 | 0.37 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |
| Paid Up Equity Capital | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | |